Skip to main content
ACR Convergence 2023 Main banner
Final Program


Schedule at a Glance
Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand
Back

Vivian Bykerk, MD, FRCPC (she/her/hers)

Hospital for Special Surgery
New York, NY, United States

Dr. Bykerk, is a Professor of Medicine at Weill Cornell Medical College, Cornell University, an Attending Rheumatologist and Director of the Inflammatory Arthritis Program at the Hospital for Special Surgery in New York with 35+ years of clinical and research experience. Her research is in early and established RA. Dr. Bykerk received her MD and epidemiology training from McMaster University, training in Internal and Critical Care Medicine at U of Toronto, and in Rheumatology at McGill University in Canada. She has practiced in community and academic settings and is now a clinical scientist, and director of the inflammatory arthritis program at the Hospital for Special Surgery. She is the PI and Director of the CATCH studies, including the Canadian Early Arthritis Cohort (CATCH) Study and more recently the Consortium of Early RA Cohorts-USA (CATCH-US). Since 2009, she has worked at the Brigham and Women's Hospital in Boston and to her current position in 2011. Dr. Bykerk and her colleagues have authored RA Practice Recommendations, developed white papers to promote early diagnosis and treatment of RA, revised the ACR EULAR RA classification criteria, and derived a patient-reported measure of RA Flare. Dr. Bykerk has provided clinical leadership to the Accelerated Medicines Partnership since 2014, aimed to deconvolute the pathophysiology of RA and construct patient subgroups per cellular-molecular signatures & phenotype. She is a dedicated researcher, mentor, and educator.

Presentation(s):